| Mendelian randomization identifies blood metabolites previously linked to midlife cognition as causal candidates in Alzheimer’s disease J Lord, B Jermy, R Green, A Wong, J Xu, C Legido-Quigley, R Dobson, ... Proceedings of the National Academy of Sciences 118 (16), e2009808118, 2021 | 43 | 2021 |
| Integrated lipidomics and proteomics network analysis highlights lipid and immunity pathways associated with Alzheimer’s disease J Xu, G Bankov, M Kim, A Wretlind, J Lord, R Green, A Hodges, A Hye, ... Translational neurodegeneration 9, 1-15, 2020 | 40 | 2020 |
| Association between polygenic risk score of Alzheimer’s disease and plasma phosphorylated tau in individuals from the Alzheimer’s Disease Neuroimaging Initiative A Zettergren, J Lord, NJ Ashton, AL Benedet, TK Karikari, ... Alzheimer's research & therapy 13, 1-10, 2021 | 35 | 2021 |
| Genetic risk for attention-deficit/hyperactivity disorder predicts cognitive decline and development of Alzheimer’s disease pathophysiology in cognitively unimpaired older adults DT Leffa, JP Ferrari-Souza, B Bellaver, C Tissot, PCL Ferreira, WS Brum, ... Molecular Psychiatry 28 (3), 1248-1255, 2023 | 11 | 2023 |
| The changing flora of the Shoalwater Bay islands E Rippey, J Rippey, N Dunlop, C Durant, B Green, J Lord Western Australian Naturalist 22, 81-104, 1998 | 10 | 1998 |
| Metabolic correlates of late midlife cognitive outcomes: findings from the 1946 British Birth Cohort R Green, J Lord, J Xu, J Maddock, M Kim, R Dobson, C Legido-Quigley, ... Brain communications 4 (1), fcab291, 2022 | 8* | 2022 |
| Sex-Specific metabolic pathways were associated with alzheimer’s disease (ad) endophenotypes in the european medical information framework for ad multimodal biomarker discovery … J Xu, R Green, M Kim, J Lord, A Ebshiana, S Westwood, AL Baird, ... Biomedicines 9 (11), 1610, 2021 | 8 | 2021 |
| A genome-wide association study of plasma phosphorylated tau181 J Lord, A Zettergren, NJ Ashton, TK Karikari, AL Benedet, J Simren, A Hye, ... Neurobiology of aging 106, 304. e1-304. e3, 2021 | 6 | 2021 |
| Disentangling independent and mediated causal relationships between blood metabolites, cognitive factors, and Alzheimer’s disease J Lord, R Green, SW Choi, C Hübel, D Aarsland, L Velayudhan, P Sham, ... Biological Psychiatry Global Open Science 2 (2), 167-179, 2022 | 5 | 2022 |
| Assessing genetic overlap and causality between blood plasma proteins and Alzheimer’s Disease A Handy, J Lord, R Green, J Xu, D Aarsland, L Velayudhan, A Hye, ... Journal of Alzheimer's Disease 83 (4), 1825-1839, 2021 | 5 | 2021 |
| Investigating associations between blood metabolites, later life brain imaging measures, and genetic risk for Alzheimer’s disease RE Green, J Lord, MA Scelsi, J Xu, A Wong, S Naomi-James, A Handy, ... Alzheimer's research & therapy 15 (1), 38, 2023 | 3 | 2023 |
| Deciphering the causal relationship between blood metabolites and Alzheimer’s Disease: a Mendelian Randomization study J Lord, B Jermy, R Green, A Wong, J Xu, C Legido-Quigley, R Dobson, ... medRxiv, 2020.04. 28.20083253, 2020 | 2 | 2020 |
| Investigating the genetic relationship between depression symptoms and Alzheimer’s Disease in clinically diagnosed and proxy cases L Gilchrist, TP Spargo, RE Green, JRI Coleman, DM Howard, JG Thorp, ... medRxiv, 2023.06. 05.23290588, 2023 | | 2023 |
| Genetic risk for attention‐deficit/hyperactivity disorder is associated with amyloid‐dependent cognitive decline in older adults DT Leffa, JP Ferrari‐Souza, B Bellaver, PCL Ferreira, C Tissot, WS Brum, ... Alzheimer's & Dementia 18, e061603, 2022 | | 2022 |
| Integrative metabolomics for the prediction and causal understanding of Alzheimer's disease risk J Lord King's College London, 2022 | | 2022 |
| Are metabolites linked to midlife cognition on the causal pathway to Alzheimer's Disease? A Mendelian randomization study J Lord, J Bradley, R Green, A Wong, J Xu, C Legido-Quigley, R Dobson, ... Proceedings of the National Academy of Sciences of the United States of …, 2021 | | 2021 |
| Sex-specific metabolic pathways associate with Alzheimer’s Disease (AD) endophenotypes in the European Medical Information Framework for AD Multimodal Biomarker Discovery cohort J Xu, R Green, M Kim, J Lord, A Ebshiana, S Westwood, AL Baird, ... medRxiv, 2021.04. 06.21254535, 2021 | | 2021 |
| Gender-specific biomarkers and pathways associated with clinical variables in the European Medical Information Framework for Alzheimer's Disease (EMIF-AD) biomarker discovery … J Xu, R Green, M Kim, J Lord, S Westwood, AL Baird, AJ Nevado-Holgado, ... AAIC Neuroscience Next, 2020 | | 2020 |
| Investigating the role of blood metabolites as biomarkers of cognitive function and dementia in the MRC 1946 British Birth Cohort R Green, J Xu, J Lord, J Maddock, M Kim, RJB Dobson, C Legido-Quigley, ... 2020 Alzheimer's Association International Conference, 2020 | | 2020 |
| S35INVESTIGATING THE ROLE OF MODIFIABLE RISK FACTORS ON THE CAUSAL PATHWAY TO ALZHEIMER'S DISEASE J Lord, R Green, C Hübel, M Richards, P Sham, C Legido-Quigley, ... European Neuropsychopharmacology 29, S132, 2019 | | 2019 |
